1 / 7

Point of Care Molecular Diagnostics Market: Research and Development Initiatives

Point of Care Molecular Diagnostics Market report gives attention to market segmentation, market size, and forecast of 2023-2032 to help stakeholders in making a good decision for the future investments.

Chakor
Télécharger la présentation

Point of Care Molecular Diagnostics Market: Research and Development Initiatives

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Point of Care Molecular Diagnostics Market Opportunity, Demand, recent trends, Major Driving Factors and Business Growth Strategies 2032

  2. Industry Insights • Point of Care Molecular Diagnostics Market is anticipated to register growth through 2032 owing to its ability to detect causative agents in case of any infectious disease emergencies. • POC molecular testing plays a vital role in TAT (turnaround time). It offers access to rapid and sensitive infectious disease diagnostic assays crucial for timely infection control, effective treatment, and accurate diagnosis. • Besides, strategic initiatives by various governmental bodies, such as funds and grants to support the development of novel products, will also positively influence the overall industry growth. For instance, in 2021, Thermo Fisher Scientific unveiled a manufacturing facility in India. The company's MagMAX Dx prefilled viral/pathogen nucleic acid isolation kits and CoviPath RT-PCR testing kits are developed to offer more precise, faster, and easy-to-use Covid testing solutions.

  3. Based on technology, the polymerase chain reaction (PCR) diagnostic test segment will register notable gains through 2032. Factors such as the budding use in research and development, medical diagnostics, constant technological advancements, increasing prevalence of diseases, and a rising geriatric population base would add to the segmental expansion. • Considering the application, the infectious disease segment accounted for 80% market share in 2022. The increasing prevalence of respiratory syncytial virus and influenza and the easy availability of rapid diagnostic tests, including screening tests for influenza A and B virus infections, will propel segmental demand over the estimated timeframe. • By end-use, the clinics segment accounted for over USD 10 billion revenue share in 2022. The increasing number of clinics, along with cost-effective treatment and portable point-of-care molecular diagnostics systems that help with accurate and timely diagnostics, will spur market growth by 2032 end.

  4. Regional Analysis • Regionally, the North America point-of-care molecular diagnostics market will register notable gains throughout 2023-2032. The growth can be attributed to the increasing adoption of point-of-care molecular diagnostics and treatment devices equipped with advanced technology. • Competitive Analysis • BioMerieux SA • Danaher Corporation • Bio-Rad Laboratories • Sysmex Corporation • Roche Diagnostics

  5. Point of Care Molecular Diagnostics Market @ https://www.gminsights.com/industry-analysis/point-of-care-poc-molecular-diagnostics-market Request for sample of this research report @ https://www.gminsights.com/request-sample/detail/2210 Request for customization @ https://www.gminsights.com/roc/2210

  6. Stay In Touch Social Media:

  7. THANK YOU www.gminsights.com

More Related